Clinical Trials Directory

Trials / Completed

CompletedNCT06614933

How Does the Type of Waveform Affect Tolerability With Transcutaneous Auricular Vagus Nerve Stimulation?

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
University of Miami · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The purpose of this research study is to investigate the effects of different forms of a gentle form of electrical stimulation applied to the ear, known as transcutaneous auricular vagus nerve stimulation (taVNS). The research team is interested in how the different forms affect comfort and tolerability, as well as how well it works.

Conditions

Interventions

TypeNameDescription
DEVICEBiphasic transcutaneous auricular vagus nerve stimulationTransauricular vagus nerve stimulation (taVNS) is a simple technique in which small surface electrodes are placed over the skin of the ear that are thought to be innervated by the auricular branch of the vagus nerve (ABVN). Participants in this group will first receive taVNS with a biphasic current, continuous at 25 Hz, for 1 hour, in-person.
DEVICEMonophasic transcutaneous auricular vagus nerve stimulationTransauricular vagus nerve stimulation (taVNS) is a simple technique in which small surface electrodes are placed over the skin of the ear that are thought to be innervated by the auricular branch of the vagus nerve (ABVN). Participants in this group will first receive taVNS with a monophasic current, with a 50% duty cycle at 25 Hz, for 1-hour, in-person.

Timeline

Start date
2024-12-15
Primary completion
2025-06-07
Completion
2025-06-07
First posted
2024-09-26
Last updated
2025-06-18

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06614933. Inclusion in this directory is not an endorsement.

How Does the Type of Waveform Affect Tolerability With Transcutaneous Auricular Vagus Nerve Stimulation? (NCT06614933) · Clinical Trials Directory